Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Perceptive Capital Solutions Corp Class A ( (PCSC) ) has provided an announcement.
On December 5, 2025, Perceptive Capital Solutions Corp and Freenome Holdings, Inc. announced a business combination agreement to create a publicly listed company. The transaction, expected to close in the first half of 2026, involves PCSC redomiciling as a Delaware corporation and being renamed Freenome, Inc., with shares listed on Nasdaq under the ticker symbol FRNM. The deal includes a $240 million PIPE financing led by Perceptive Advisors and RA Capital, with the combined company anticipated to have a post-transaction equity value of approximately $1.1 billion. This strategic move aims to accelerate Freenome’s development of its AI/ML-driven multiomics platform for cancer detection and expand its commercial infrastructure for the anticipated 2026 launch of multiple blood-based cancer tests.
More about Perceptive Capital Solutions Corp Class A
Freenome Holdings, Inc. is a company specializing in early cancer detection through the development of blood-based tests. The company utilizes a multiomics platform combined with artificial intelligence and machine learning to detect cancer at its earliest stages. Perceptive Capital Solutions Corp (PCSC) is a special purpose acquisition company focused on life sciences, sponsored by Perceptive Advisors.
Average Trading Volume: 8,455
Technical Sentiment Signal: Strong Buy
Current Market Cap: $23.07M
For detailed information about PCSC stock, go to TipRanks’ Stock Analysis page.